Integrated BioPharma, Inc. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced sales was USD 17.072 million compared to USD 13.631 million a year ago. Operating income was USD 1.719 million compared to USD 960,000 a year ago. Net income was USD 1.241 million compared to USD 936,000 a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.03 a year ago. For the nine months, sales was USD 46.501 million compared to USD 39.234 million a year ago. Operating income was USD 4.472 million compared to USD 2.641 million a year ago. Net income was USD 3.506 million compared to USD 2.207 million a year ago. Basic earnings per share from continuing operations was USD 0.12 compared to USD 0.07 a year ago. Diluted earnings per share from continuing operations was USD 0.11 compared to USD 0.07 a year ago.